Literature DB >> 8064078

A combined respiratory and cutaneous hypersensitivity syndrome induced by work exposure to quaternary amines.

J A Bernstein1, T Stauder, D I Bernstein, I L Bernstein.   

Abstract

The quaternary amine, benzalkonium chloride, has been associated with cutaneous and mucosal delayed hypersensitivity reactions and with paradoxical bronchoconstriction after use of aerosolized asthma medications. Until now, quaternary amines have not been reported to cause occupational asthma. We describe a case of occupational asthma caused by prolonged exposure to a cleaning solution containing benzalkonium chloride in the workplace. Single-blind, placebo-controlled, open-room challenges were performed to determine the specific agent responsible for the patient's symptoms. Pulmonary function and epicutaneous challenge tests were also performed. The patient had positive responses to challenges with a liquid toilet bowl cleaner containing benzalkonium chloride but was unreactive to other agents tested. Removal from the workplace resulted in complete resolution of symptoms. The exact mechanisms responsible for occupational asthma induced by quaternary amines remain unknown; however, this case emphasizes the importance of recognizing reactive chemicals as possible causes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064078     DOI: 10.1016/0091-6749(94)90048-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  18 in total

Review 1.  Contribution of antimicrobials to the development of allergic disease.

Authors:  Stacey E Anderson; Lisa Weatherly; Hillary L Shane
Journal:  Curr Opin Immunol       Date:  2019-06-08       Impact factor: 7.486

2.  Air and Surface Sampling Method for Assessing Exposures to Quaternary Ammonium Compounds Using Liquid Chromatography Tandem Mass Spectrometry.

Authors:  Ryan F LeBouf; Mohammed Abbas Virji; Anand Ranpara; Aleksandr B Stefaniak
Journal:  Ann Work Expo Health       Date:  2017-07-01       Impact factor: 2.179

3.  Asthma symptoms in women employed in domestic cleaning: a community based study.

Authors:  M Medina-Ramón; J P Zock; M Kogevinas; J Sunyer; J M Antó
Journal:  Thorax       Date:  2003-11       Impact factor: 9.139

4.  Evaluation of the irritancy and hypersensitivity potential following topical application of didecyldimethylammonium chloride.

Authors:  Stacey E Anderson; Hillary Shane; Carrie Long; Ewa Lukomska; B Jean Meade; Nikki B Marshall
Journal:  J Immunotoxicol       Date:  2016-05-23       Impact factor: 3.000

5.  Lung function and chronic respiratory symptoms of pig farmers: focus on exposure to endotoxins and ammonia and use of disinfectants.

Authors:  L Preller; D Heederik; J S Boleij; P F Vogelzang; M J Tielen
Journal:  Occup Environ Med       Date:  1995-10       Impact factor: 4.402

6.  Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.

Authors:  Xaver Baur; Prudence Bakehe; Henning Vellguth
Journal:  J Occup Med Toxicol       Date:  2012-09-26       Impact factor: 2.646

7.  Characterization of occupational exposures to cleaning products used for common cleaning tasks--a pilot study of hospital cleaners.

Authors:  Anila Bello; Margaret M Quinn; Melissa J Perry; Donald K Milton
Journal:  Environ Health       Date:  2009-03-27       Impact factor: 5.984

8.  Anaphylaxis caused by benzalkonium in a nebulizer solution.

Authors:  Sang-Hoon Kim; Youngsoo Ahn
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

9.  Opportunities and obstacles in translating evidence to policy in occupational asthma.

Authors:  Susan M Tarlo; Ahmed A Arif; George L Delclos; Paul Henneberger; Jenil Patel
Journal:  Ann Epidemiol       Date:  2017-03-31       Impact factor: 3.797

10.  Anaphylactic reaction following administration of nose drops containing benzalkonium chloride.

Authors:  Elke Mezger; Olaf Wendler; Susanne Mayr; Alessandro Bozzato
Journal:  Head Face Med       Date:  2012-10-18       Impact factor: 2.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.